M&A Deal Summary

Aragen Life Sciences Acquires Intox

On December 15, 2021, Aragen Life Sciences acquired life science company Intox

Acquisition Highlights
  • This is Aragen Life Sciences’ 3rd transaction in the Life Science sector.
  • This is Aragen Life Sciences’ 1st transaction in India.

M&A Deal Summary

Date 2021-12-15
Target Intox
Sector Life Science
Buyer(s) Aragen Life Sciences
Deal Type Add-on Acquisition

Target

Intox

Pune, India
Intox is a reputed GLP certified pre-clinical contract research organization (CRO) with its test facilities. Intox was founded in 1995 and is based in Pune, India.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Aragen Life Sciences

Hyderabad, India

Category Company
Founded 2001
Sector Life Science
DESCRIPTION

Aragen Life Sciences is a provider of outsourced discovery, development, and manufacturing services across both large and small molecule platforms. Aragen Life Sciences was founded in 2001 and is based in Hyderabad, Telangana.


DEAL STATS #
Overall 3 of 3
Sector: Life Science M&A 3 of 3
Type: Add-on Acquisition M&A Deals 3 of 3
Country: India M&A 1 of 1
Year: 2021 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2014-11-07 Vanta Bioscience LC

Des Moines, Iowa, United States

Vanta Bioscience is a provider of pre-clinical contract research organization with research laboratories.

Buy -